Myocardial revascularization by percutaneous coronary intervention: past, present, and the future.

[1]  William Grossman,et al.  Grossman & Baim's Cardiac Catheterization, Angiography, and Intervention , 2013 .

[2]  S. Yusuf,et al.  Stemming the global tsunami of cardiovascular disease , 2011, The Lancet.

[3]  Usama Bilal,et al.  Challenges and opportunities for cardiovascular disease prevention. , 2011, The American journal of medicine.

[4]  Matti Niemelä,et al.  Simple or Complex Stenting for Bifurcation Coronary Lesions: A Patient-Level Pooled-Analysis of the Nordic Bifurcation Study and the British Bifurcation Coronary Study , 2011, Circulation. Cardiovascular interventions.

[5]  S. Yusuf,et al.  Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial , 2010, The Lancet.

[6]  Doris A Taylor,et al.  LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction. , 2010, Texas Heart Institute journal.

[7]  David X M Zhao,et al.  Contemporary Reviews in Interventional Cardiology Surgical Update Hybrid Procedures , Do They Have a Role ? , 2010 .

[8]  S. Yusuf,et al.  Dose comparisons of clopidogrel and aspirin in acute coronary syndromes. , 2010, The New England journal of medicine.

[9]  Patrick W Serruys,et al.  Coronary stents: looking forward. , 2010, Journal of the American College of Cardiology.

[10]  F. Kiemeneij,et al.  Transradial access for primary percutaneous coronary intervention: the next standard of care? , 2010, Heart.

[11]  Inder Singh,et al.  Drug‐eluting stents versus bare‐metal stents for treatment of bare‐metal in‐stent restenosis , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  K. Rufibach,et al.  Cell-based therapy for myocardial repair in patients with acute myocardial infarction: rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). , 2010, American heart journal.

[13]  M. Mack,et al.  Outcomes in Patients With De Novo Left Main Disease Treated With Either Percutaneous Coronary Intervention Using Paclitaxel-Eluting Stents or Coronary Artery Bypass Graft Treatment in the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) Trial , 2010, Circulation.

[14]  C. Cannon.  Strategies and Therapies for Reducing Ischemic and Vascular Events (STRIVE): updated standing orders for ST-segment elevation myocardial infarction and unstable angina/non-ST-segment elevation myocardial infarction. , 2010, Critical pathways in cardiology.

[15]  S. Cha,et al.  Percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis of data from the ARTS II, CARDia, ERACI III, and SYNTAX studies and systematic review of observational data. , 2010 .

[16]  Deepak L. Bhatt,et al.  The state of periprocedural antiplatelet therapy after recent trials. , 2010, JACC. Cardiovascular interventions.

[17]  Sunil V. Rao,et al.  The transradial approach to percutaneous coronary intervention: historical perspective, current concepts, and future directions. , 2010, Journal of the American College of Cardiology.

[18]  S. Mehta,et al.  Aspirin for Acute Coronary Syndromes: Have We Learned the Correct Dose Yet? , 2010, Current cardiology reports.

[19]  N. Kukreja,et al.  Drug-eluting balloon: new tool in the box , 2010, Expert review of medical devices.

[20]  E. Mahmud,et al.  Comparison by meta-analysis of drug-eluting stents and bare metal stents for saphenous vein graft intervention. , 2010, The American journal of cardiology.

[21]  G. Leclerc,et al.  COMPARE-AMI Trial: Comparison of Intracoronary Injection of CD133+ Bone Marrow Stem Cells to Placebo in Patients After Acute Myocardial Infarction and Left Ventricular Dysfunction: Study Rationale and Design , 2010, Journal of cardiovascular translational research.

[22]  B. Strauss,et al.  Intraplaque therapies for facilitating percutaneous recanalization of chronic total occlusions. , 2010, The Canadian journal of cardiology.

[23]  J. Moses,et al.  Contemporary principles of coronary chronic total occlusion recanalization , 2010, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[24]  M. Nazzaro,et al.  Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial. , 2010, Journal of the American College of Cardiology.

[25]  T. Henry,et al.  Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN) , 2010, Journal of cardiovascular translational research.

[26]  Samin K. Sharma,et al.  Coronary bifurcation lesions: a current update. , 2010, Cardiology clinics.

[27]  J. Jensen,et al.  Cardioprotective Effects of Ischemic Postconditioning in Patients Treated With Primary Percutaneous Coronary Intervention, Evaluated by Magnetic Resonance , 2010, Circulation. Cardiovascular interventions.

[28]  Inder Singh,et al.  Clinical outcomes of drug‐eluting versus bare‐metal in‐stent restenosis , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[29]  S. Werns.  Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes , 2010 .

[30]  Gregg W Stone,et al.  Platelet inhibition with cangrelor in patients undergoing PCI. , 2009, The New England journal of medicine.

[31]  Deepak L. Bhatt,et al.  Intravenous platelet blockade with cangrelor during PCI. , 2009, The New England journal of medicine.

[32]  Ingrid M. Nembhard,et al.  National efforts to improve door-to-balloon time results from the Door-to-Balloon Alliance. , 2009, Journal of the American College of Cardiology.

[33]  H. Ting,et al.  Quality dimensions of primary percutaneous coronary intervention: timeliness, access, and availability. , 2009, Circulation.

[34]  B. Gersh,et al.  Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. , 2009, The New England journal of medicine.

[35]  Antonio Colombo,et al.  Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. , 2009, The New England journal of medicine.

[36]  J. Ornato,et al.  2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST‐Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update) , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[37]  Ed Parsonage,et al.  Biomaterial considerations for drug-eluting stents , 2009, 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[38]  David X M Zhao,et al.  Combined PCI and minimally invasive heart valve surgery for high-risk patients , 2009, Current treatment options in cardiovascular medicine.

[39]  Deepak L. Bhatt,et al.  Drug-eluting versus bare-metal stents for treating saphenous vein grafts. , 2009, American heart journal.

[40]  G. De Luca,et al.  Long-Term outcome of drug-eluting stents compared with bare metal stents in ST-segment elevation myocardial infarction: results of the paclitaxel- or sirolimus-eluting stent versus bare metal stent in Primary Angioplasty (PASEO) Randomized Trial. , 2009, Circulation.

[41]  R. Califf,et al.  Careers for Clinician Investigators , 2009, Circulation.

[42]  W. Ahmad.  Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes. , 2009 .

[43]  P. Avanzas,et al.  Embolic protection devices in saphenous percutaneous intervention. , 2009, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[44]  S. Iyengar,et al.  Use of magnetic guidewire navigation in the treatment of lower extremity peripheral vascular disease: Report of the first human clinical experience , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[45]  G. Lemesle,et al.  Paclitaxel‐eluting balloon: From bench to bed , 2009, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[46]  J. D. de Lemos,et al.  Clinical ResearchInterventional CardiologyA Randomized Controlled Trial of a Paclitaxel-Eluting Stent Versus a Similar Bare-Metal Stent in Saphenous Vein Graft Lesions: The SOS (Stenting Of Saphenous Vein Grafts) Trial , 2009 .

[47]  D. Holmes,et al.  Adjunctive Thrombectomy and Distal Protection in Primary Percutaneous Coronary Intervention: Impact on Microvascular Perfusion and Outcomes , 2009, Circulation.

[48]  H. Thiele,et al.  Intracoronary administration of bone marrow-derived progenitor cells improves left ventricular function in patients at risk for adverse remodeling after acute ST-segment elevation myocardial infarction: results of the Reinfusion of Enriched Progenitor cells And Infarct Remodeling in Acute Myocardial , 2009, American heart journal.

[49]  P. Teirstein.  Percutaneous Revascularization Is the Preferred Strategy for Patients With Significant Left Main Coronary Stenosis , 2009, Circulation.

[50]  John A McPherson,et al.  Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room. , 2009, Journal of the American College of Cardiology.

[51]  Antonio Colombo,et al.  Randomized Study of the Crush Technique Versus Provisional Side-Branch Stenting in True Coronary Bifurcations: The CACTUS (Coronary Bifurcations: Application of the Crushing Technique Using Sirolimus-Eluting Stents) Study , 2009, Circulation.

[52]  B. Gersh.  Thrombus Aspiration during Primary Percutaneous Coronary Intervention , 2009 .

[53]  D. Vaughan,et al.  Hybrid cardiovascular procedures. , 2008, JACC. Cardiovascular interventions.

[54]  Harlan M Krumholz,et al.  Implementation and integration of prehospital ECGs into systems of care for acute coronary syndrome: a scientific statement from the American Heart Association Interdisciplinary Council on Quality of Care and Outcomes Research, Emergency Cardiovascular Care Committee, Council on Cardiovascular Nursi , 2008, Circulation.

[55]  Fang-Shu Ou,et al.  Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous coronary intervention: a report from the National Cardiovascular Data Registry. , 2008, JACC. Cardiovascular interventions.

[56]  David R. Holmes,et al.  Catheter-Based Treatment of Coronary Artery Disease: Past, Present, and Future , 2008, Circulation. Cardiovascular interventions.

[57]  R. Blumenthal,et al.  Placing COURAGE in context: review of the recent literature on managing stable coronary artery disease. , 2008, Mayo Clinic proceedings.

[58]  F. Zijlstra,et al.  Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study , 2008, The Lancet.

[59]  E. Hannan,et al.  Drug-Eluting Stents vs Coronary-Artery Bypass Grafting in Multivessel Coronary Disease , 2008 .

[60]  Deepak L. Bhatt,et al.  Comparison of drug-eluting stents versus bare-metal stents for treating ST-segment elevation myocardial infarction. , 2008, JACC. Cardiovascular interventions.

[61]  E. Topol,et al.  Facilitated PCI in patients with ST-elevation myocardial infarction. , 2008, The New England journal of medicine.

[62]  B. Gersh,et al.  Bivalirudin during primary PCI in acute myocardial infarction. , 2008, The New England journal of medicine.

[63]  D. Holmes,et al.  Safety and efficacy of drug‐eluting stent for ST‐segment elevation myocardial infarction in an unselected consecutive cohort , 2008, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[64]  Young-Hak Kim,et al.  Stents versus coronary-artery bypass grafting for left main coronary artery disease. , 2008, The New England journal of medicine.

[65]  M. Bell,et al.  Major femoral bleeding complications after percutaneous coronary intervention: incidence, predictors, and impact on long-term survival among 17,901 patients treated at the Mayo Clinic from 1994 to 2005. , 2008, JACC. Cardiovascular interventions.

[66]  Guido Germano,et al.  Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden: Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy , 2008, Circulation.

[67]  B. Gersh,et al.  Percutaneous coronary intervention for chronic stable angina: a reassessment. , 2008, JACC. Cardiovascular interventions.

[68]  B. Gersh,et al.  Systems of care to improve timeliness of reperfusion therapy for ST-segment elevation myocardial infarction during off hours: the Mayo Clinic STEMI protocol. , 2008, JACC. Cardiovascular interventions.

[69]  P. Teirstein,et al.  A collaborative systematic review and meta-analysis on 1278 patients undergoing percutaneous drug-eluting stenting for unprotected left main coronary artery disease. , 2008, American heart journal.

[70]  V. Fuster,et al.  Design of the Future REvascularization Evaluation in patients with Diabetes mellitus: Optimal management of Multivessel disease (FREEDOM) Trial. , 2008, American heart journal.

[71]  H. Krumholz,et al.  A campaign to improve the timeliness of primary percutaneous coronary intervention: Door-to-Balloon: An Alliance for Quality. , 2008, JACC. Cardiovascular interventions.

[72]  R. Wilensky,et al.  A comparison of bare-metal and drug-eluting stents for off-label indications. , 2008, The New England journal of medicine.

[73]  R. Higgins,et al.  Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. , 2008, The New England journal of medicine.

[74]  A. Jacobs,et al.  Task force 3: training in diagnostic and interventional cardiac catheterization endorsed by the Society for Cardiovascular Angiography and Interventions. , 2008, Journal of the American College of Cardiology.

[75]  W. Howard,et al.  Optimal Medical Therapy with or without PCI for Stable Coronary Disease , 2008 .

[76]  S. Werns.  Benefit of Early Invasive Therapy in Acute Coronary Syndromes: A Meta-Analysis of Contemporary Randomized Clinical Trials , 2008 .

[77]  B. Gersh.  Trends in Outcomes After Percutaneous Coronary Intervention for Chronic Total Occlusions: A 25-Year Experience From the Mayo Clinic , 2008 .

[78]  D. Kereiakes.  Specialized centers and systems for heart attack care. , 2008, The American heart hospital journal.

[79]  John Bresnahan,et al.  Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents , 2007, Circulation.

[80]  E. Antman,et al.  Prasugrel versus clopidogrel in patients with acute coronary syndromes. , 2007, The New England journal of medicine.

[81]  Simon Wandel,et al.  Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis , 2007, The Lancet.

[82]  J. Ormiston,et al.  The AST petal dedicated bifurcation stent: First‐in‐human experience , 2007, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[83]  P. Serruys,et al.  Drug-Eluting Stent Update 2007: Part II: Unsettled Issues , 2007, Circulation.

[84]  Inder Singh,et al.  High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.

[85]  B. Gersh,et al.  Regional Systems of Care to Optimize Timeliness of Reperfusion Therapy for ST-Elevation Myocardial Infarction: The Mayo Clinic STEMI Protocol , 2007, Circulation.

[86]  P. Serruys,et al.  Thrombosis and drug-eluting stents: an objective appraisal. , 2007, Journal of the American College of Cardiology.

[87]  Brett Trauthen,et al.  Six-month clinical and angiographic results of a dedicated drug-eluting stent for the treatment of coronary bifurcation narrowings. , 2007, The American journal of cardiology.

[88]  B. Lewis,et al.  Percutaneous coronary intervention in patients receiving enoxaparin or unfractionated heparin after fibrinolytic therapy for ST-segment elevation myocardial infarction in the ExTRACT-TIMI 25 trial. , 2007, Journal of the American College of Cardiology.

[89]  Antonio Colombo,et al.  Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation , 2007, Circulation.

[90]  S. Steinhubl,et al.  Optimizing platelet P2Y12 inhibition for patients undergoing PCI. , 2007, Cardiovascular drug reviews.

[91]  R. Virmani,et al.  Pathological Correlates of Late Drug-Eluting Stent Thrombosis: Strut Coverage as a Marker of Endothelialization , 2007, Circulation.

[92]  C. Yancy,et al.  Thrombosis in Coronary Drug-Eluting Stents: Report From the Meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006* , 2007, Circulation.

[93]  L. Wallentin,et al.  Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction - Reply , 2007 .

[94]  Ralph D'Agostino,et al.  Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.

[95]  D. Holmes,et al.  Left main coronary artery stenosis: state-of-the-art. , 2007, Current problems in cardiology.

[96]  W. Frishman.  Bivalirudin for Patients with Acute Coronary Syndromes , 2007 .

[97]  B. Gersh,et al.  Percutaneous coronary intervention vs thrombolysis for ST-elevation myocardial infarction. , 2007, Journal of the American Medical Association (JAMA).

[98]  C. Rihal,et al.  Narrative Review: Reperfusion Strategies for ST-Segment Elevation Myocardial Infarction , 2006, Annals of Internal Medicine.

[99]  D. Berman,et al.  Rheolytic thrombectomy with percutaneous coronary intervention for infarct size reduction in acute myocardial infarction: 30-day results from a multicenter randomized study. , 2006, Journal of the American College of Cardiology.

[100]  Samin K. Sharma,et al.  Impact of Completeness of Percutaneous Coronary Intervention Revascularization on Long-Term Outcomes in the Stent Era , 2006, Circulation.

[101]  P. Teirstein,et al.  Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. , 2006, JAMA.

[102]  G. Stone,et al.  Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial. , 2006, JAMA.

[103]  David X M Zhao,et al.  Combined percutaneous coronary intervention and valve surgery. , 2006, Current opinion in cardiology.

[104]  D. Holmes,et al.  Drug-eluting coronary stents. , 2006, Current problems in cardiology.

[105]  A. Ionescu,et al.  Bare metal stent restenosis is not a benign clinical entity. , 2006, American heart journal.

[106]  Patrick W Serruys,et al.  Percutaneous coronary intervention for chronic total occlusions: the Thoraxcenter experience 1992-2002. , 2005, European heart journal.

[107]  Gary S. Mintz,et al.  Percutaneous Recanalization of Chronically Occluded Coronary Arteries: A Consensus Document Part II , 2005, Circulation.

[108]  J. Tijssen,et al.  Early invasive versus selectively invasive management for acute coronary syndromes. , 2005, The New England journal of medicine.

[109]  B. Gersh,et al.  One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. , 2005, The Journal of thoracic and cardiovascular surgery.

[110]  Deepak L. Bhatt.  To cath or not to cath: that is no longer the question. , 2005, JAMA.

[111]  E. Hannan,et al.  Outcomes of planned home births with certified professional midwives: large prospective study in North America , 2005, BMJ : British Medical Journal.

[112]  R. Gibbons,et al.  Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. , 2005, JAMA.

[113]  Antonio Colombo,et al.  Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. , 2005, Circulation.

[114]  Deepak L. Bhatt,et al.  Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative , 2004 .

[115]  Charles L. Brown,et al.  Analysis of 1-Year Clinical Outcomes in the SIRIUS Trial: A Randomized Trial of a Sirolimus-Eluting Stent Versus a Standard Stent in Patients at High Risk for Coronary Restenosis , 2004, Circulation.

[116]  Eric J Topol,et al.  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. , 2002, JAMA.

[117]  A. Mattioli,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[118]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[119]  P. Barragan,et al.  Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction , 2001 .

[120]  J. Keaney.  Grossman's cardiac catheterization, angiography, and intervention, 6th ed , 2001 .

[121]  S. Yusuf,et al.  Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. , 2001, The New England journal of medicine.

[122]  E. Topol,et al.  Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization. , 2001, The New England journal of medicine.

[123]  K. Detre,et al.  Immediate and one-year outcome in patients with coronary bifurcation lesions in the modern era (NHLBI dynamic registry). , 2001, The American journal of cardiology.

[124]  R. Bersin,et al.  Results of the study to determine rotablator and transluminal angioplasty strategy (STRATAS). , 2001, The American journal of cardiology.

[125]  B. Rutherford,et al.  Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: a 20-year experience. , 2001, Journal of the American College of Cardiology.

[126]  M. Schwaiger,et al.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators. , 2000, The New England journal of medicine.

[127]  C. Heeschen,et al.  Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels. c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators. , 1999, The New England journal of medicine.

[128]  D. Baim,et al.  Balloon angioplasty versus new device intervention: clinical outcomes. A comparison of the NHLBI PTCA and NACI registries. , 1998, Journal of the American College of Cardiology.

[129]  L. Klein,et al.  Six month outcome and determinants of adverse clinical events after successful excimer laser coronary angioplasty. ELCA A.I.S. Multicenter Registry. , 1995, The Journal of invasive cardiology.

[130]  R. Califf,et al.  One-year follow-up in the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT I) , 1995, Circulation.

[131]  R. Califf,et al.  A multicenter, randomized trial of coronary angioplasty versus directional atherectomy for patients with saphenous vein bypass graft lesions. CAVEAT-II Investigators. , 1995, Circulation.

[132]  C M Gibson,et al.  Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. , 1993, Journal of the American College of Cardiology.

[133]  R E Vlietstra,et al.  Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1988, Journal of the American College of Cardiology.

[134]  F Joffre,et al.  Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. , 1987, The New England journal of medicine.

[135]  T. Ryan,et al.  Follow-up of patients from the coronary artery surgery study (CASS) potentially suitable for percutaneous transluminal coronary angioplasty. , 1983, American heart journal.

[136]  D. Holmes,et al.  Percutaneous transluminal coronary angioplasty: initial Mayo Clinic experience. , 1981, Mayo Clinic proceedings.

[137]  W. Siegenthaler,et al.  Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.

[138]  A. Grüntzig,et al.  Technique of percutaneous transluminal angioplasty with the Grüntzig ballon catheter. , 1979, AJR. American journal of roentgenology.

[139]  A Gruntzig,et al.  Transluminal dilatation of coronary-artery stenosis. , 1978, Lancet.